Literature DB >> 9344699

Complement activation in severe Plasmodium falciparum malaria.

C Wenisch1, S Spitzauer, K Florris-Linau, H Rumpold, S Vannaphan, B Parschalk, W Graninger, S Looareesuwan.   

Abstract

We determined indices of plasma complement activation (C3, C4, Bb, C4d, iC3b, and SC5b-9), levels of tumor necrosis factor (TNF) and interleukin-6, and the APACHE II score in 23 patients with complicated Plasmodium falciparum malaria. On admission, plasma concentrations of Bb, SC5b-9, and C4d were markedly increased compared to healthy control subjects (n = 24) (4.5 +/- 1.9 vs 1.5 +/- 0.6 mg/L; 1125.7 +/- 496.9 vs 183.2 +/- 76.5 microg/L; and 15.7 +/- 5.7 vs 7.2 +/- 1.4 mg/L, P < 0.01 for all). In contrast C3 and iC3b concentrations were decreased (631.4 +/- 247 vs 947.3 +/- 243.2 and 105 +/- 17.9 vs 151.3 +/- 14.5 mg/L; P < 0.01 for both). Plasma C4 concentrations in malaria were not different from normal controls. Plasma Bb, C3, and iC3b levels normalized on day 7 of treatment, whereas SC5b-9 and C4d levels remained elevated. A significant correlation between elevated TNF levels and Bb (r = 0.507) and SC5b-9 (r = 0.448, P < 0.01 for both) and a negative correlation between iC3b and SC5b-9 and TNF levels existed (r = -0.537 and r = -0.466, P < 0.01 for both). In addition, a significant correlation between C3 and iC3b (r = 0.689) and C4 and C4d (r = 0.737) existed. However, no relation between clinical disease severity and complement fragments existed. The results demonstrate that both the classical and the alternative pathways of the complement system are profoundly activated in complicated malaria. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344699     DOI: 10.1006/clin.1997.4417

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  19 in total

1.  Regioselectively modified sulfated cellulose as prospective drug for treatment of malaria tropica.

Authors:  Reinhard Schwartz-Albiez; Yvonne Adams; Claus-W von der Lieth; Petra Mischnick; Katherine T Andrews; Michael Kirschfink
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

Review 2.  Development of complement therapeutics for inhibition of immune-mediated red cell destruction.

Authors:  Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2005-08       Impact factor: 3.157

3.  Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites.

Authors:  P R Taylor; E Seixas; M J Walport; J Langhorne; M Botto
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors.

Authors:  Pedro Mejia; Monica Diez-Silva; Faustin Kamena; Fengxin Lu; Stacey M Fernandes; Peter H Seeberger; Alvin E Davis; James R Mitchell
Journal:  J Infect Dis       Date:  2015-09-07       Impact factor: 5.226

Review 5.  Blood coagulation, inflammation, and malaria.

Authors:  Ivo M B Francischetti; Karl B Seydel; Robson Q Monteiro
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

6.  New inflammation-related biomarkers during malaria infection.

Authors:  Fikregabrail Aberra Kassa; Marina Tiemi Shio; Marie-Josée Bellemare; Babacar Faye; Momar Ndao; Martin Olivier
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

7.  Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers.

Authors:  Sandipan Ray; Durairaj Renu; Rajneesh Srivastava; Kishore Gollapalli; Santosh Taur; Tulip Jhaveri; Snigdha Dhali; Srinivasarao Chennareddy; Ankit Potla; Jyoti Bajpai Dikshit; Rapole Srikanth; Nithya Gogtay; Urmila Thatte; Swati Patankar; Sanjeeva Srivastava
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240

8.  Complement consumption in children with Plasmodium falciparum malaria.

Authors:  Nancy K Nyakoe; Ronald P Taylor; Joseph N Makumi; John N Waitumbi
Journal:  Malar J       Date:  2009-01-09       Impact factor: 2.979

9.  C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria.

Authors:  Andrea Conroy; Lena Serghides; Constance Finney; Simon O Owino; Sanjeev Kumar; D Channe Gowda; W Conrad Liles; Julie M Moore; Kevin C Kain
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

10.  Complement activation in Ghanaian children with severe Plasmodium falciparum malaria.

Authors:  Gideon K Helegbe; Bamenla Q Goka; Joergen A L Kurtzhals; Michael M Addae; Edwin Ollaga; John K A Tetteh; Daniel Dodoo; Michael F Ofori; George Obeng-Adjei; Kenji Hirayama; Gordon A Awandare; Bartholomew D Akanmori
Journal:  Malar J       Date:  2007-12-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.